BioClinica acquires CardioNow from Agfa

Clinical trial services supplier BioClinica has acquired the CardioNow unit of Agfa HealthCare for an undisclosed sum.

With the acquisition, the Newtown, Pa.-based BioClinica said it now offers electronic transport solutions to facilitate the blinding, sharing, tracking and archiving of medical images for multi-center clinical trials as part of its suite of imaging services. Imaging information will also be integrated with BioClinica Express electronic data capture to simplify and enhance the clinical trial process for life science companies.

BioClinica said that CardioNow has successfully managed more than 8.8 million DICOM images for global clinical studies over the past 10 years. With the integration of CardioNow, BioClinica will be able to manage the process that begins once a medical image is acquired at a clinical site through the delivery of evaluated results to the sponsor.

Around the web

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Trimed Popup
Trimed Popup